Douglas C. Lane & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-403
Closed -$206K 244
2015
Q2
$206K Buy
+403
New +$206K 0.01% 221